Yahoo Web Search

Search results

1. • 

     Diagnosing Psoriatic Arthritis for the Dermatologist

     Medscape· 2 days ago

     Editor's note: Drs Gottlieb and Merola refer to the following presentation throughout their discussion: Masterclasses in Dermatology™: Masterclass in ...

2. • Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...

     Morningstar· 2 days ago

     Food and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara®, for the treatment of moderate to severe plaque psoriasis ...

3. • 

     Death After Hemorrhoid Cream; Working Late and Illness; Full-Blown Hoarding

     MedPage Today· 2 days ago

     A California woman died of lead poisoning associated with use of castor oil hemorrhoid ointment...

4. • Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant...

     KOLR - KSFX Ozarks· 16 hours ago

     − Results from the Phase 3 SELECT-GCA study showed 46 percent of patients with giant cell arteritis (GCA) who were treated with upadacitinib (RINVOQ®; 15 mg) with a 26-week steroid taper regimen ...

5. • Galapagos (NASDAQ:GLPG) Reaches New 52-Week Low at $29.45

     ETF DAILY NEWS· 24 hours ago

     Shares of Galapagos NV (NASDAQ:GLPG – Get Free Report) reached a new 52-week low on Tuesday . The company traded as low as $29.45 and last traded at $29.49, with a volume of 16106 shares. The ...

6. • Amgen Inc. (NASDAQ:AMGN) Short Interest Update

     ETF DAILY NEWS· 21 hours ago

     Amgen Inc. (NASDAQ:AMGN – Get Free Report) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 10,470,000 shares, a decline ...

7. • FY2024 EPS Estimates for Bristol-Myers Squibb (NYSE:BMY) Reduced by William Blair

     ETF DAILY NEWS· 22 hours ago

     Bristol-Myers Squibb (NYSE:BMY – Free Report) – Stock analysts at William Blair lowered their FY2024 earnings per share (EPS) estimates for Bristol-Myers Squibb in a research note issued to ...

8. • Clarus Group Inc. Reduces Stock Position in Johnson & Johnson (NYSE:JNJ)

     ETF DAILY NEWS· 16 hours ago

     Clarus Group Inc. trimmed its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 39.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & ...

9. • Bristol-Myers Squibb (NYSE:BMY) Short Interest Down 5.7% in March

     ETF DAILY NEWS· 21 hours ago

     Bristol-Myers Squibb (NYSE:BMY – Get Free Report) saw a significant decline in short interest in March. As of March 31st, there was short interest totalling 35,120,000 shares, a decline of 5.7% ...

10. • Wealthspan Partners LLC Raises Holdings in Johnson & Johnson (NYSE:JNJ)

      ETF DAILY NEWS· 16 hours ago

      Wealthspan Partners LLC boosted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 6.0% during the fourth quarter, according to its most recent disclosure with the Securities and ...